Figure 6. Kaplan-Meier estimates of progression-free survival (ribociclib + letrozole vs placebo + letrozole) by
geographical region9. Adapted from: Yap YS, et al. ESMO Asia 2016. Abstract LBA1.
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
Figure 6. Kaplan-Meier estimates of progression-free survival (ribociclib + letrozole vs placebo + letrozole) by
geographical region9. Adapted from: Yap YS, et al. ESMO Asia 2016. Abstract LBA1.